ACM
Altium Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,251
| Closed | -$2.02M | – | 17 |
|
|
2025
Q1 | $2.02M | Sell |
60,251
-227,749
| -79% | -$7.64M | 4.87% | 7 |
|
|
2024
Q4 | $11.3M | Sell |
288,000
-72,600
| -20% | -$2.85M | 3.2% | 7 |
|
|
2024
Q3 | $14.2M | Hold |
360,600
| – | – | 4.18% | 5 |
|
|
2024
Q2 | $14.1M | Buy |
360,600
+12,600
| +4% | +$491K | 5.74% | 3 |
|
|
2024
Q1 | $15M | Buy |
348,000
+57,465
| +20% | +$2.47M | 5.93% | 2 |
|
|
2023
Q4 | $13.4M | Buy |
290,535
+62,535
| +27% | +$2.88M | 9.08% | 1 |
|
|
2023
Q3 | $7.79M | Hold |
228,000
| – | – | 4.06% | 10 |
|
|
2023
Q2 | $8.78M | Buy |
+228,000
| New | +$8.78M | 6.64% | 5 |
|
|
2021
Q4 | – | Sell |
-216,000
| Closed | -$3.3M | – | 155 |
|
|
2021
Q3 | $3.3M | Buy |
216,000
+61,000
| +39% | +$932K | 0.87% | 49 |
|
|
2021
Q2 | $2.89M | Buy |
+155,000
| New | +$2.89M | 0.67% | 62 |
|